CL-S001 (Cellusion)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCL-S001 (Cellusion)
Drug Alias Namecorneal endothelial substitute cell therapy (Cellusion)iPSC-derived corneal endothelial cell substitutes (Cellusion)induced pluripotent stem cell-derived corneal endothelial cell therapy (Cellusion)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCorneal Edema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanMacau +[6] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesCellusion Inc
China Registration ClassN/A

Develop Information

Active CompaniesCalregen IncCellusion Inc
Inactive CompaniesN/A
Active IndicationsCorneal Edema
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A